 |
|
|||||
Dr. Kathryn Swoboda received her medical degree from Northwestern University in Chicago, Illinois. She completed an internship in medicine at the Evanston Hospital in Chicago, and her neurology residency training at the Harvard Longwood Program in Boston, Massachusetts. She stayed in Boston to complete subspecialty fellowship training in neurophysiology (EMG) and clinical genetics at Harvard at the Boston Children's Hospital and Lahey Clinic Medical Center. Currently, she is an associate professor of Neurology and Pediatrics at the University of Utah, where she directs the Pediatric Motor Disorders Research Program. Her research efforts are directed to identifying new treatments for children with motor disorders. She is a principal investigator for Project Cure SMA, a multi-center research network established in collaboration with Families of SMA to help facilitate the rapid translation of new therapies to clinical trials for patients with spinal muscular atrophy. Dr. Swoboda will be the Principal Investigator for California Stem Cell's SMA Type I clinical trial. |
StemBlast Media® Specialized, proprietary, serum-free media designed for the propagation of hESCs and hiPSCs. Live Cells on Demand! California Stem Cell is now shipping high purity populations of fully characterized hESC-derived human cells in an ideal format for drug screening and predictive toxicology. |
|||||
